Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial*Steven M. Opal, John P. Pribble, Thierry Dugernier et al.|Critical Care Medicine|2004Cited by 145
Nangibotide in patients with septic shock: a Phase 2a randomized controlled clinical trialBruno François, Pierre‐François Laterre, Xavier Wittebole et al.|Intensive Care Medicine|2020Cited by 71
The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public–Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial Pneumonia: Table 1.Bruno François, Hasan S. Jafri, Jean Chastre et al.|Clinical Infectious Diseases|2016Cited by 26
Suvratoxumab Reduces Staphylococcus Aureus Pneumonia in High-Risk ICU Patients: Results of the SAATELLITE StudyBruno François, SAATELLITE Study Group, Miguel Sánchez et al.|Unknown|2019Cited by 6